Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
11 April 2018 09:03
Scientists have announced their latest breakthrough in the battle against Alzheimer's disease
Scientists have announced their latest breakthrough in the battle against Alzheimer's disease, after neutralising a high-risk gene in a human brain cell for the first time.
A California-based team successfully identified the responsible protein (associated with the apoE4 gene) and then succeeded in stopping it from damaging human neuron cells.
New potential
The study could mean new potential for halting the disease, though scientists are keen to take the research one step at a time, as, so far, their compound has only been tried on cells in a laboratory.
People with one copy of the apoE4 gene are twice as likely to develop Alzheimer's disease, while having two copies increases the risk 12-fold.
According to previous studies, roughly one in four people have the gene, which creates a misshapen protein that breaks down into disease-causing fragments in the cells.
This results in the development of problems commonly associated with Alzheimer's disease, which affects about 7.1% of Britons over the age of 65.
Next steps
The researchers are now working with the pharmaceutical industry to improve the compounds they've developed in order to test them on human beings.
Yadong Huang, who led the study, which is published in Nature Medicine, said: "Drug development for Alzheimer's disease has been largely a disappointment over the last 10 years.
"Many drugs work beautifully in a mouse model, but so far they've all failed in clinical trials.
"One concern within the field has been how poorly these mouse models really mimic human disease."
Huang and his colleagues went straight for human brain cells rather than the traditional mouse trial because they realised the presence of the apoE4 gene does not change the production of amyloid beta in a mouse brain.
Last month senior British scientists predicted that within the next few decades Alzheimer's sufferers will be able to live with the disease without the devastating symptoms.
If you're travelling with a family member suffering from Alzheimer's, don't forget to sort the specific insurance package to cover them.
18 January 2019
A plant-based diet is needed to protect future generations and safeguard the wellbeing of the planet, according to experts.
[more...]
17 January 2019
Campaigners are protesting outside the High Court in London as the legal challenge against Heathrow Airport's controversial expansion ramps up.
16 January 2019
A new way to predict a woman's risk of breast cancer has been unveiled by scientists - and it's the most comprehensive method yet.
15 January 2019
NHS commissioners could be slapped with a £2,500 fine for every patient left waiting more than a year for vital care, new proposals suggest.
12 January 2019
All UK airports should buy anti-drone technology and not rely on the Royal Air Force to help out, Defence Secretary Gavin Williamson has said.
10 January 2019
The military was brought in on Tuesday night after police officers saw a drone operating at Heathrow Airport, forcing departures to be suspended for an hour.
11 January 2019
A so-called "drug sponge" that mops up leftover drugs from cancer treatment could improve the effectiveness of chemotherapy, new research has claimed.
09 January 2019
A hormone released during exercise could help protect the brain from Alzheimer's disease, new research suggests.
08 January 2019
Ryanair has been labelled the worst airline operating in the UK for the sixth year running in a leading consumer group survey.
05 January 2019
Anti-drone technology will be deployed at the UK's two busiest airports in response to the disruption caused before Christmas.
04 January 2019
A new cancer-detecting breathalyser test is being trialled in the UK - in a move that could revolutionise the way the disease is diagnosed.
03 January 2019
The average 10-year-old child will have already eaten more sugar in their life than the maximum amount recommended for 18-year-olds, a new study reveals.